The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Larger Will The Cancer Stem Cells Market Become By 2030 Compared To 2026?
The cancer treatment facilities market size has demonstrated significant expansion in recent years. It is anticipated to increase from $48.27 billion in 2025 to reach $52.19 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 8.1%. Historically, this expansion can be linked to several factors: an upward trend in global cancer incidence rates, the enlargement of hospital oncology departments, the widespread availability of chemotherapy and radiation technologies, a heightened public awareness of early cancer detection, and an increase in the number of trained oncology professionals.
The market size for cancer treatment facilities is expected to experience significant growth over the next few years. It is forecast to expand to $70.52 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period is primarily attributed to heightened investments in cancer research infrastructure, the increasing adoption of immunotherapy and targeted therapies, the broader expansion of personalized medicine approaches, the growing application of digital health in oncology care, and the rising demand for integrated cancer treatment services. Notable trends anticipated in the forecast period include the increasing uptake of precision oncology treatments, the rising integration of advanced diagnostic technologies, the expanding use of multidisciplinary care models, the further development of specialized cancer centers, and an enhanced focus on patient-centric care.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27235&type=smp
What Primary Factors Are Fueling The Expansion Of The Cancer Stem Cells Market?
The increasing occurrence of cancer is projected to fuel the expansion of the cancer treatment facilities market in the future. Cancer is defined as a collection of illnesses marked by the unregulated multiplication and dissemination of atypical cells throughout the body. This surge in cancer cases stems from an aging populace, which boosts the count of individuals in advanced age brackets, a demographic with a considerably elevated risk of developing cancer. Cancer treatment centers play a crucial role in managing the escalating burden of cancer by providing timely diagnosis, sophisticated therapeutic alternatives, and ongoing patient support, all vital for enhancing patient longevity and well-being. As an illustration, a report from September 2025 by the American Association for Cancer Research (AACR), a US-based professional body dedicated to the prevention and cure of cancer, highlighted an estimated 20 million new cancer cases and over 10.3 million cancer-related deaths globally in 2025, alongside approximately 53.5 million people surviving at least 5 years after a cancer diagnosis. Consequently, the increasing incidence of cancer is propelling the expansion of the cancer treatment facilities market.
How Is The Cancer Stem Cells Market Examined Through Segment Analysis?
The cancer stem cells market covered in this report is segmented –
1) By Type: Solid Tumor Stem Cells, Hematopoietic Stem Cells, Breast Cancer Stem Cells, Colorectal Cancer Stem Cells, Brain Cancer Stem Cells, Leukemia Stem Cells
2) By Cancer Forms: Breast, Blood, Lung, Brain, Colorectal, Pancreatic, Bladder, Liver, Other Cancer Forms
3) By Mode Of Action: Targeted Cancerous Stem Cells (Cscs), Stem Cell-Based Cancer Therapy
4) By Research Type: Basic Research, Clinical Research, Preclinical Research, Translational Research
5) By End User: Pharmaceutical And Biotechnology Companies, Research And Academic Institutions, Hospitals And Laboratories, Contract Research Organizations (CROs)
Subsegments:
1) By Solid Tumor Stem Cells: Lung Cancer Stem Cells, Liver Cancer Stem Cells, Pancreatic Cancer Stem Cells, Prostate Cancer Stem Cells, Ovarian Cancer Stem Cells
2) By Hematopoietic Stem Cells: Myeloid Stem Cells, Lymphoid Stem Cells, Erythroid Stem Cells, Megakaryocytic Stem Cells, Granulocytic Stem Cells
3) By Breast Cancer Stem Cells: Triple Negative Breast Cancer Stem Cells, Hormone Receptor Positive Breast Cancer Stem Cells, Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Stem Cells, Metastatic Breast Cancer Stem Cells, Inflammatory Breast Cancer Stem Cells
4) By Colorectal Cancer Stem Cells: Adenocarcinoma Colorectal Cancer Stem Cells, Mucinous Colorectal Cancer Stem Cells, Signet Ring Cell Colorectal Cancer Stem Cells, Metastatic Colorectal Cancer Stem Cells, Serrated Colorectal Cancer Stem Cells
5) By Brain Cancer Stem Cells: Glioblastoma Stem Cells, Medulloblastoma Stem Cells, Astrocytoma Stem Cells, Oligodendroglioma Stem Cells, Ependymoma Stem Cells
6) By Leukemia Stem Cells: Acute Myeloid Leukemia Stem Cells, Chronic Myeloid Leukemia Stem Cells, Acute Lymphoblastic Leukemia Stem Cells, Chronic Lymphocytic Leukemia Stem Cells, Mixed Phenotype Acute Leukemia Stem Cells
Which Trends Are Affecting The Cancer Stem Cells Market Framework?
Companies operating in the cancer treatment facilities market are increasingly focusing on sophisticated treatment technologies, such as electron beam therapy, to enhance the accuracy and effectiveness of cancer care. Electron beam therapy involves using high-energy electrons to treat cancer by targeting tumors located close to the body’s surface. As an illustration, in October 2024, Aster DM Healthcare Limited, a UAE-based healthcare company, launched intraoperative electron radiation therapy (IOeRT) for its cancer care treatment facilities. Intraoperative electron radiation therapy (IOeRT) offers distinct features, including the delivery of a high-dose, single-fraction electron beam directly to the tumor bed during surgery, utilizing direct visualization to precisely target residual cancer cells while physically shielding or retracting healthy tissues. The application of high-energy electrons, typically ranging from 4–12 MeV, ensures a sharp dose fall-off, thereby limiting radiation exposure to deeper layers.
Who Are The Leading Firms Participating In The Cancer Stem Cells Market?
Major companies operating in the cancer stem cells market are MacroGenics Inc., Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc., Lonza Group AG, A. Menarini Industrie Farmaceutiche Riunite S.r.l., Bio-Techne Corporation, Zymeworks Inc., Kura Oncology Inc., GeneTex Inc., YZY Biopharma Co. Ltd., Abnova Taiwan Corporation, BioView Ltd., ScienCell Research Laboratories Inc., Boster Biological Technology Co. Ltd., AAT Bioquest Inc., Celprogen Inc., Actinium Pharmaceuticals Inc., OncoMed Pharmaceuticals Inc., Fate Therapeutics Inc., Verastem Oncology Inc.
Access The Complete Cancer Stem Cells Market Report:
https://www.thebusinessresearchcompany.com/report/cancer-stem-cells-global-market-report
Which Regional Market Leads The Cancer Stem Cells Market?
North America was the largest region in the cancer stem cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer stem cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Cancer Stem Cells Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=27235&type=smp
Browse Through More Reports Similar to the Global Cancer Stem Cells Market 2026, By The Business Research Company
Cancer Tumor Profiling Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
Cancer Biomarker Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report
Cancer Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model